Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Persano I, Parlagreco E, La Salvia A, Audisio M, Volante M, Buttigliero C, Scagliotti GV, Brizzi MP.
Semin Oncol. 2022 Dec;49(6):476-481. doi: 10.1053/j.seminoncol.2023.01.007. Epub 2023 Feb 2.
PMID:36759234
Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
Konukiewitz B, Jesinghaus M, Kasajima A, Klöppel G.
Virchows Arch. 2022 Feb;480(2):247-257. doi: 10.1007/s00428-021-03211-5. Epub 2021 Oct 13.
PMID:34647171
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.
Scott AT, Howe JR.
Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27.
PMID:31255207
Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature.
Mortaji P, Morris KT, Samedi V, Eberhardt S, Ryan S.